Fig. 2: Western Blot of BGN protein expression in skin fibroblasts of probands from families 1, 6, 9, 10, 17, and 18 as well as matched controls. | npj Genomic Medicine

Fig. 2: Western Blot of BGN protein expression in skin fibroblasts of probands from families 1, 6, 9, 10, 17, and 18 as well as matched controls.

From: Expanding the clinical spectrum of biglycan-related Meester-Loeys syndrome

Fig. 2: Western Blot of BGN protein expression in skin fibroblasts of probands from families 1, 6, 9, 10, 17, and 18 as well as matched controls.

Intracellular proteins were isolated from skin fibroblast samples and the biglycan (BGN) protein content was visualized. Cyclophilin B (CypB) was used as a loading control. Family 17 and 18 were reported as family 4 and 5, respectively, by Meester et al.1. Controls 1–4 were samples of age-matched male controls. The Western Blot was derived from one experiment and all lanes were processed in parallel.

Back to article page